Wonbiogen (307280) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Wonbiogen (307280) reported revenue of 35.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202535.2 billion KRW7.9 billion KRW6.5 billion KRW[source]
202430.4 billion KRW6.4 billion KRW5.3 billion KRW[source]
202329.6 billion KRW7.1 billion KRW6.0 billion KRW[source]
202226.7 billion KRW5.2 billion KRW3.3 billion KRW[source]
202117.7 billion KRW2.0 billion KRW-660 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202546.6 billion KRW3.8 billion KRW42.8 billion KRW[source]
202440.0 billion KRW2.9 billion KRW37.1 billion KRW[source]
202342.5 billion KRW8.9 billion KRW33.6 billion KRW[source]
202238.7 billion KRW10.7 billion KRW28.0 billion KRW[source]
202136.4 billion KRW8.9 billion KRW27.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice